Literature DB >> 26328247

Expression and significance of m1A transmethylase, hTrm6p/hTrm61p and its related gene hTrm6/hTrm61 in bladder urothelial carcinoma.

Lei Shi1, Xiao-Ming Yang1, Dong-Dong Tang2, Gang Liu3, Pu Yuan3, Yang Yang1, Lian-Sheng Chang1, Li-Rong Zhang4, Dong-Kui Song1.   

Abstract

OBJECTIVE: To discuss the expression of hTrm6p/hTrm61p in bladder urothelial carcinoma tissue and its relationship with m1A level in urine, as well as the influences of hTrm6/hTrm61 on the proliferation and apoptosis of cancer cell line on urothelium.
METHODS: m1A levels in urine of 32 patients of bladder urothelial carcinoma and normal people were detected by HPLC/ESI-Q-TOF-MS, hTrm6p/hTrm61p expression levels in cancer tissue and para-carcinoma tissue of the same patient were detected by western blotting, and hTrm61 expressions of cancer cell line T24, 5637, and EJ of bladder urothelium and kidney cell line HEK-293 of human embryo were detected by RT-qPCR. The hTrm61 high-expression cell line is selected to detect the situation of proliferation and apoptosis by CCK-8 and flow cytometry (FCM) after knocking out hTrm61 with siRNA.
RESULTS: m1A level in urine of carcinoma of urinary bladder is significantly higher than that of normal people, and hTrm6p/hTrm61p expression level in cancer tissue is significantly higher than that in para-carcinoma tissue and has linear correlation with m1A level in urine. The hTrm61 expression in cell line 5637 is significantly higher than that of T24, EJ, and HEK293, and apoptosis is significantly affected after hTrm61 is knocked out from 5637 cell line.
CONCLUSION: High-level expression of hTrm6p/hTrm61p is an important reason for high emission of m1A in urine, and hTrm6/hTrm61 promotes the occurrence of carcinoma of urinary bladder.

Entities:  

Keywords:  Bladder urothelial carcinoma; HPLC/ESI-Q-TOF-MS; hTrm6/hTrm61; hTrm6p/hTrm61p; m1A; urinary modified nucleosides

Year:  2015        PMID: 26328247      PMCID: PMC4548328     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  19 in total

1.  Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.

Authors:  G Xu; H R Schmid; X Lu; H M Liebich; P Lu
Journal:  Biomed Chromatogr       Date:  2000-11       Impact factor: 1.902

2.  Urinary modified nucleosides as novel biomarkers for diagnosis and prognostic monitoring of urothelial bladder cancer.

Authors:  Yu-Rui Zhang; Lei Shi; Hui Wu; Dong-Dong Tang; Shao-Min Wang; Hong-Min Liu; Li-Rong Zhang; Dong-Kui Song
Journal:  Tumori       Date:  2014 Nov-Dec       Impact factor: 2.098

3.  Modified nucleosides as biomarkers for early cancer diagnose in exposed populations.

Authors:  Annerose Seidel; Peter Seidel; Olaf Manuwald; Olf Herbarth
Journal:  Environ Toxicol       Date:  2014-02-24       Impact factor: 4.119

4.  Mammalian ALKBH8 possesses tRNA methyltransferase activity required for the biogenesis of multiple wobble uridine modifications implicated in translational decoding.

Authors:  Lene Songe-Møller; Erwin van den Born; Vibeke Leihne; Cathrine B Vågbø; Terese Kristoffersen; Hans E Krokan; Finn Kirpekar; Pål Ø Falnes; Arne Klungland
Journal:  Mol Cell Biol       Date:  2010-02-01       Impact factor: 4.272

5.  Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/electrospray tandem mass spectrometry.

Authors:  Hua-Yu Li; Shao-Min Wang; Hong-Min Liu; Shan-Shan Bu; Juan Li; Dong Han; Ming-zhi Zhang; Guang-Yin Wu
Journal:  J Mass Spectrom       Date:  2009-05       Impact factor: 1.982

6.  Nuclear surveillance and degradation of hypomodified initiator tRNAMet in S. cerevisiae.

Authors:  Sujatha Kadaba; Anna Krueger; Tamyra Trice; Annette M Krecic; Alan G Hinnebusch; James Anderson
Journal:  Genes Dev       Date:  2004-05-14       Impact factor: 11.361

7.  Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.

Authors:  Wei-Yi Hsu; William Tzu-Liang Chen; Wei-De Lin; Fuu-Jen Tsai; Yuhsin Tsai; Ching-Tsung Lin; Wan-Yu Lo; Long-Bin Jeng; Chien-Chen Lai
Journal:  Clin Chim Acta       Date:  2008-12-16       Impact factor: 3.786

8.  Urinary nucleosides based potential biomarker selection by support vector machine for bladder cancer recognition.

Authors:  Yong Mao; Xiaoping Zhao; Shufang Wang; Yiyu Cheng
Journal:  Anal Chim Acta       Date:  2007-07-21       Impact factor: 6.558

9.  Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control.

Authors:  A Seidel; S Brunner; P Seidel; G I Fritz; O Herbarth
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640

10.  Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in Taiwanese.

Authors:  Wei-Yi Hsu; Chao-Jung Chen; Yu-Chuen Huang; Fuu-Jen Tsai; Long-Bin Jeng; Chien-Chen Lai
Journal:  PLoS One       Date:  2013-12-19       Impact factor: 3.240

View more
  13 in total

1.  RNA modifications and cancer.

Authors:  Phensinee Haruehanroengra; Ya Ying Zheng; Yubin Zhou; Yun Huang; Jia Sheng
Journal:  RNA Biol       Date:  2020-02-07       Impact factor: 4.652

2.  Expression and Potential Biomarkers of Regulators for M7G RNA Modification in Gliomas.

Authors:  Zhen Chen; Zhe Zhang; Wei Ding; Jie-Hui Zhang; Zi-Long Tan; Yu-Ran Mei; Wei He; Xiao-Jing Wang
Journal:  Front Neurol       Date:  2022-05-09       Impact factor: 4.086

3.  Matching tRNA modifications in humans to their known and predicted enzymes.

Authors:  Valérie de Crécy-Lagard; Pietro Boccaletto; Carl G Mangleburg; Puneet Sharma; Todd M Lowe; Sebastian A Leidel; Janusz M Bujnicki
Journal:  Nucleic Acids Res       Date:  2019-03-18       Impact factor: 16.971

4.  m1A Regulated Genes Modulate PI3K/AKT/mTOR and ErbB Pathways in Gastrointestinal Cancer.

Authors:  Yueshui Zhao; Qijie Zhao; Parham Jabbarzadeh Kaboli; Jing Shen; Mingxing Li; Xu Wu; Jianhua Yin; Hanyu Zhang; Yuanlin Wu; Ling Lin; Lingling Zhang; Lin Wan; Qinglian Wen; Xiang Li; Chi Hin Cho; Tao Yi; Jing Li; Zhangang Xiao
Journal:  Transl Oncol       Date:  2019-07-25       Impact factor: 4.243

5.  Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer.

Authors:  Qingyuan Zheng; Xiao Yu; Qiyao Zhang; Yuting He; Wenzhi Guo
Journal:  Biosci Rep       Date:  2021-04-30       Impact factor: 3.840

Review 6.  Elucidating the Functions of Non-Coding RNAs from the Perspective of RNA Modifications.

Authors:  Venkata Naga Srikanth Garikipati; Shizuka Uchida
Journal:  Noncoding RNA       Date:  2021-05-11

Review 7.  RNA modifications act as regulators of cell death.

Authors:  Lei Xu; Chong Zhang; Hang Yin; Shuai Gong; Nai Wu; Zeqiang Ren; Yi Zhang
Journal:  RNA Biol       Date:  2021-07-27       Impact factor: 4.766

8.  Transformation-induced stress at telomeres is counteracted through changes in the telomeric proteome including SAMHD1.

Authors:  Jana Majerska; Marianna Feretzaki; Galina Glousker; Joachim Lingner
Journal:  Life Sci Alliance       Date:  2018-07-17

Review 9.  Epigenetic modulations of noncoding RNA: a novel dimension of Cancer biology.

Authors:  Xiao Yang; Ming Liu; Mengmeng Li; Sen Zhang; Hong Hiju; Jing Sun; Zhihai Mao; Minhua Zheng; Bo Feng
Journal:  Mol Cancer       Date:  2020-03-24       Impact factor: 27.401

10.  Gene signatures and prognostic values of m1A-related regulatory genes in hepatocellular carcinoma.

Authors:  Qingmiao Shi; Chen Xue; Xin Yuan; Yuting He; Zujiang Yu
Journal:  Sci Rep       Date:  2020-09-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.